Login | New Member? Signup Free
ChangeDetect » News

Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims

DEERFIELD, IL–(Marketwire – Feb 6, 2013) – Horizon Pharma, Inc. today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application 13/428,548 entitled "Delayed Release Tablet with Defined Core Geometry" that covers the Company's U.S. approved product RAYOS ® .

Tags: , , , , , , , , , , , , , , , , ,